Results 171 to 180 of about 4,929,883 (200)

Anal cancer: Current standards in care and recent changes in practice

Ca-A Cancer Journal for Clinicians, 2015
David Shibata
exaly  

Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial

Lancet, The, 2018
Matsatoshi Kudo, Richard Finn, Kwang-Hyub Han   +2 more
exaly  

Lines 1-332

2007
openaire   +1 more source

Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial

Lancet, The, 2019
Stuart R Dalziel, Meredith L Borland, Jeremy S Furyk   +2 more
exaly  

First-line chemotherapy for mCRC—a review and evidence-based algorithm

Nature Reviews Clinical Oncology, 2015
Chiara Cremolini, Marta Schirripa, Roberto Moretto   +2 more
exaly  

Naples Underground Line 1

V. Manassero, F. Giannelli, S. Spada
openaire   +1 more source

Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial

Lancet, The, 2013
Dieter Hoelzer
exaly  

Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial

Lancet, The, 2017
Matthew D Galsky, Thomas Powles, Joaquim Bellmunt   +2 more
exaly  

Drawing the Line 1

2016
openaire   +1 more source

Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial

Lancet, The, 2011
Timothy S Maughan, Richard Adams, Richard H Wilson   +2 more
exaly